Johnson & Johnson (JNJ) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 EPS Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $260.35 -0.66%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.82, $0.10 better than the analyst estimate of $2.72. Revenue for the quarter came in at $22.45 billion versus the consensus estimate of $22.34 billion.
GUIDANCE:
Johnson & Johnson sees FY2024 EPS of $10.05, versus the consensus of $10.01.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Boeing lands two U.S. defense contracts worth over $711M
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
